BioAgilytix
BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across industries and disease states.
Strategies for Overcoming Drug Interference in Immunogenicity Assessment
ADA Assessment for Cell Therapies
Total Bioanalytical Support for Antibody−Drug Conjugates (ADCs)
PK Assessment for Advanced Modalities (Cell and Gene Therapies)
Immediate hypersensitivity reactions against biologicals
What the new AAPS White Paper recommends for immunogenicity assays supporting biosimilars
Recent aspects and challenges in the assessment of immunogenicity
Webinar Q&A follow up – Clinical relevance of (unwanted drug-induced) immune responses
Clinical relevance of (unwanted drug-induced) immune responses
Bioanalytical methods in support of biosimilar drug development
BioAgilytix appoints Nathan Speicher as Chief Financial Officer
BioAgilytix Appoints Euan Menzies as Chairman and Chief Executive Officer
Panel discussion: lessons learnt from COVID-19 and lab 4.0
Panel discussion: ICH M10 draft bioanalytical method validation guideline
Pharmacokinetic Bioequivalence of ATI-0918 and DOXIL®/CAELYX® in Patients with Ovarian Cancer
Efficient and Economical Preclinical Pharmacokinetic Analyses
In the Zone: ADA assessment and detection
Infographic: the facts about anti-drug antibodies
Is ISR Needed For Biomarker Assays? – Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis
Determining Immunogenicity for CAR-T cell Therapies – Bioanalytical Lab & Top CRO for Large Molecule
Clinical relevance of immunogenicity: an interview with Arno Kromminga
Exploratory biomarker testing: to qualify or validate the assay?
Website: www.bioagilytix.com
Email: [email protected]
Telephone: 919-381-6097
Address: 2300 Englert Drive, Durham, NC, 27713, USA